S. Sidney (September 1997). "Marijuana use and cancer incidence (California, United States)". Cancer Causes and Control 8 (5): 722-728.
J. Huff & P. Chan (October 2000). "Antitumor Effects of THC". Environmental Health Perspectives 108 (10): A442-3.
K.A. Rosenblatt et al. (1 June 2004). "Marijuana Use and Risk of Oral Squamous Cell Carcinoma". Cancer Research 64: 4049-4054.
Parolaro and Massi. 2008. Cannabinoids as a potential new drug therapy for the treatment of gliomas. Expert Reviews of Neurotherapeutics 8: 37-49
Galanti et al. 2007. Delta9-Tetrahydrocannabinol inhibits cell cycle progression by downregulation of E2F1 in human glioblastoma multiforme cells. Acta Oncologica 12: 1-9.
Calatozzolo et al. 2007. Expression of cannabinoid receptors and neurotrophins in human gliomas. Neurological Sciences 28: 304-310.
Ramer and Hinz. 2008. Inhibition of cancer cell invasion by cannabinoids via increased cell expression of tissue inhibitor of matrix metalloproteinases-1. Journal of the National Cancer Institute 100: 59-69.
Preet et al. 2008. Delta9-Tetrahydrocannabinol inhibits epithelial growth factor-induced lung cancer cell migration in vitro as well as its growth and metastasis in vivo. Oncogene 10: 339-346.